FDAnews Device Daily Bulletin

Allergan Releases Positive Data for Tear Stimulator

May 17, 2016

Allergan has released positive data from two pivotal trials evaluating its Oculeve intranasal tear neurostimulator, a handheld stimulator with disposable tips for the treatment of dry eye disease. 

The device met its primary and secondary endpoints of increased tear production and the company is planning on a premarket submission for the device during the latter half of this year. — Anisa Jibrell


View More Stories